Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
Meletios A Dimopoulos, Pieter Sonneveld, Salomon Manier, Annette Lam, Tito Roccia, Jordan M. Schecter, Patricia Cost, Lida Pacaud, Abbey E. Poirier, Gabriel Tremblay, Tommy Lan, Satish Valluri, Shaji Kumar (2024). Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma. , 24(1), DOI: https://doi.org/10.1186/s12885-024-12263-0.
Article33 days agoQuality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
Gabriel Tremblay, Patrick Daniele, Janis L. Breeze, Lingling Li, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay K. Nooka, Dan T. Vogl, Maria Gavriatopoulou, Meletios A Dimopoulos, Paul G. Richardson, Noa Biran, David S. Siegel, Philip Vlummens, Chantal Doyen, Thierry Façon, Mohamad Mohty, Nathalie Meuleman, Moshe Levy, Luciano J. Costa, James E. Hoffman, Michel Delforge, David Kaminetzky, Katja Weisel, Marc S. Raab, David Dingli, Sascha A. Tuchman, Laurent Frenzel, Ravi Vij, Gary J. Schiller, Philippe Moreau, Joshua Richter, Martin Schreder, Klaus Podar, Terri L. Parker, Robert F. Cornell, Lionel Karlin, Sylvain Choquet, Sundar Jagannath (2021). Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study. , 21(1), DOI: https://doi.org/10.1186/s12885-021-08453-9.
Article33 days ago